ArticleOne health (Amsterdam, Netherlands)2026
Elevated risk of hepatitis E virus infection among sheep smallholders in Xinjiang, China.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis E virus (HEV) is an emerging zoonotic pathogen that infects both humans and domestic animals. Although HEV has been detected in sheep, the risks of transmission along the food chain via the mutton industry chain remain poorly characterized. This study aimed to assess the occupational risk of HEV infection among sheep industry workers. A cross-sectional survey was conducted among sheep workers in various settings, including smallholder farms, slaughterhouses, and retail markets. Serum samples from these workers, as well as from individuals in the general population, were collected and tested for anti-HEV IgM and IgG antibodies using commercial ELISA kits. Risk factors for HEV seropositivity across different occupational environments were analyzed using logistic regression. The seropositivity rate among sheep industry workers was 53.0% (132/249), significantly higher than that in the general population (13.3%, 33/249). Multi-variable analysis revealed a markedly increased risk of HEV infection among smallholder sheep farmers (adjusted OR = 10.1, 95% CI: 6.3-16.3). In contrast, there was no significantly elevated risk among people working in retail markets or slaughterhouses. The results indicate that occupational exposure to sheep is associated with a heightened risk of HEV infection, particularly in smallholder farm settings. Strengthening HEV control measures for HEV in high-risk occupational environments is essential for long-term public health prevention and elimination efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.